Skip to main content
Log in

Nifedipine as low-dose monotherapy for essential hypertension: A primary care study

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bayley S, Dobbs RJ, Robinson BF. Nifedipine in the treatment of hypertension: Report of a double-blind controlled trial. Br J Clin Pharmacol 1982;14:509–512.

    Google Scholar 

  2. Heagerty AM, Swales J, Baksi A, et al. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Br Med J 1988;296:468–472.

    Google Scholar 

  3. Murphy MB, Scriven AJI, Dollery CT. Role of nifedipine in treatment of hypertension. Br Med J 1983;287:257–259.

    Google Scholar 

  4. Opie LH, Jee L, White D. Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. Am Heart J 1982;104:606–612.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ritchie, L.D., Harrington, L.T., MacGregor, A.R. et al. Nifedipine as low-dose monotherapy for essential hypertension: A primary care study. Cardiovasc Drug Ther 3 (Suppl 1), 341 (1989). https://doi.org/10.1007/BF00148480

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00148480

Key Words

Navigation